SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Bulgaria
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Borola (Борола)

Main Activities: Pharmaceutical and Medicine Manufacturing - Drugs and Druggists' Sundries Merchant Wholesalers

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Borola EOOD (Борола ЕООД)

Headquarters
Ovcha kupel 2 District, bl. 2a; Sofia; Sofia - city; 1632
Status: Non-Listed
Legal Form: Limited Liability Company
Operational Status: Operational
BG VAT Identification Code: BG121121771
BULSTAT: 121121771
Total Employees: 47

Tel: (+359 2) 915 61 00, 495 13 68

Company Description

Healthcare company Borola was established in 1996. The firm is primarily engaged in wholesaling pharmaceutical products. It is also active in the manufacture and trade in food supplements. Borola is an official distributor of Pharma Swiss, LEO Pharmaceutocal Products, For Tuniqne, Capsugel and Gerresheimer for Bulgaria.

Company Analysis

According to the Individual - Audited financial statement for the Year of 2011, total net operating revenues decreased with -16.76%, from BGN 5,735 thousands to BGN 4,774 thousands. Operating result decreased from BGN 1,476 thousands to BGN 1,350 thousands which means -8.54% change. The results of the period decreased -5.64% reaching BGN 1,055 thousands at the end of the period against BGN 1,118 thousands last year. Return on equity (Net income/Total equity) went from 31.48% to 26.33%, the Return On Asset (Net income / Total Asset) went from 16.76% to 15.51% and the Net Profit Margin (Net Income/Net Sales) went from 19.49% to 22.10% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 69.80% compared to 87.84% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.32 to 1.17 when compared to the previous year.

Key Executives

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

6,804

6,672

Current Assets

X,XXX

X,XXX

Total Liabilities

X,XXX

X,XXX

Shareholders Equity

X,XXX

X,XXX

Current Liabilities

X,XXX

X,XXX

* All the accounts are in BGN.
Income Statement

Total Operating Revenue

X,XXX

X,XXX

Operational Profit (Loss)

X,XXX

X,XXX

Net Profit (Loss)

X,XXX

X,XXX

* All the accounts are in BGN.
Ratios
Profitability Ratios

Return on Assets (ROA)

XX.XX%

XX.XX%

Annualised Return on Assets (ROA)

XX.XX%

XX.XX%

Return on Equity (ROE)

XX.XX%

XX.XX%

Annualised Return on Equity (ROE)

XX.XX%

XX.XX%

Return on Sales (ROS)

XX.XX%

XX.XX%

Return on Capital

XX.XX%

XX.X%

Gross Profit Margin

XX.XX%

XX.XX%

Operating Profit Margin

XX.XX%

XX.XX%

Efficiency Ratios

Inventory Turnover

X.XXx

X.XXx

Current asset turnover

X.XXx

X.XXx

Fixed-asset turnover

X.XXx

X.XXx

Asset Turnover

X.Xx

X.XXx

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

X,XXX

X,XXX

EBITDA

X,XXX

X,XXX

Bookvalue (BV)

X,XXX

X,XXX

Net Cash

-X,XXX

-X,XXX

Liquidity Ratios

Current Ratio

XXX.XX%

XXX.XX%

Quick ratio

XX.XX%

XX.XX%

Doom's day ratio

XX.XX%

XX.XX%

Leverage Ratios

Leverage ratio

XXX.X%

XXX.XX%

Debt to equity

XX.X%

XX.XX%

Debt to total assets

XX.XX%

XX.XX%

Long Term Debt to Capital

XX.XX%

XX.XX%

Trend Ratios

Revenue Trend

XX.XX%

XXX.XX%

Net Income Trend

XX.XX%

XX.X%

Operating Income Trend

XX.XX%

XX.XX%